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in secondary spongious zone and diaphyseal cortical bone and
slightly in primary spongious area, and iii) bone microarchitecture
showed higher values of BV/TV, Tb.th, Tb.N and lower value of
Tb.Spin treated rats. Finally, we demonstrated that the overproduc-
tion of RANKL and IL-17 in sera of arthritic animals was prevented
by pioglitazone treatment.
Conclusions: In the present study, we demonstrated that pi-
oglitazone had bone protective properties in arthritis-induced in-
ﬂammation. The concomitant decrease of circulating IL-17 and
RANKL levels strongly suggests that pioglitazone anti-resorptive
effect is likely supported by the modulation of the IL-17-RANKL
osteoclastogenesis pathway.
157
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Purpose: Studies of animal models of osteoarthritis undergoing
anti-resorptive therapy have suggested that inactivation of bone re-
sorption leads to improved articular cartilage status. However, the
role of osteoclasts, and subchondral bone turnover, still remains
to be elucidated. In alignment, an increasing amount of research
is devoted to the cellular phenotype associated with disease sta-
tus. The osteoclast phenotype associated with osteoarthritis has
not been investigated. We developed a pure human osteoclast
system, and investigated the cellular phenotype on various bone
substrates; cortical, trabecular and calcitﬁed cartilage.
Methods: CD14+ monocytes were isolated from human peripheral
blood using a ﬁcoll gradient and magnetic sorting. For investigation
of osteoclastogenesis the CD14+ cells were seeded on either
cortical bovine bone slices or plastic with 25ng/mL RANKL and M-
CSF in the presence or absence of 17β-estradiol (0.001-10nM) and
cultured for 21 days. For mature human osteoclast experiments
CD14+ cells were cultured in ﬂasks for 10 days, and the lifted and
reseeded onto different matrices and cultured for another 10 days
in the presence or absence of well-characterized bone resorption
inhibitors (calcitonin (1nM-1μM), ibandronate (1μM) and diphyllin
(300nM)). Osteoclastogenesis was assayed using the osteoclast
marker Tartrate Resistant Acid Phosphatase (TRACP), as well
as TRACP staining. Bone resorption was assayed by calcium
release and CTX-I (C-terminal Telopeptide of Type I Collagen) all in
cell culture supernatants. Immunocytochemistry for the calcitonin
receptor (CTR) and TRACP was performed on both precursors
and mature osteoclasts on bone. Finally, mature osteoclasts were
seeded on calciﬁed cartilage from bovine knee joints, human
trabecular bone from vertebrae and human cortical bone from
femurs in the presence or absence of resorption inhibitors.
Results: Osteoclastogenesis was clearly seen when measuring
TRACP, CTX-I and calcium release, with TRACP release initiated
on day 5 of culture and CTX-I and calcium release on day 7.
All markers were increased more than 500% (P<0.01), compared
to initial values. TRACP staining conﬁrmed the presence of large
multinucleated TRACP positive cells. For the mature human os-
teoclasts intense bone resorption was observed within 24 hours
after seeding on bovine bone slices, and bone resorption was
attenuated by more than 70% in the presence of the resorption
inhibitors (P<0.01). Immunocytochemistry for CTR and TRACP
clearly demonstrated the presence of mature osteoclasts. Inter-
estingly human osteoclasts also resorbed the calciﬁed cartilage,
the human trabecular and cortical bones, although differences
in the level of resorption were observed, suggesting an induc-
tion of distinct osteoclast phenotypes that is dependent on the
extracellular matrix at which they are activated.
Conclusions: We have demonstrated that CD14+ monocytes iso-
lated from human peripheral blood are a highly useful source of
osteoclasts, which are characterized by expression of the CTR,
TRACP and bone resorption, all which are hallmarks of osteo-
clast function. We used this high quality osteoclast preparation to
demonstrate that osteoclasts resorb calciﬁed cartilage, and since
this process is involved in the pathogenesis of OA this system
can be used for characterizing osteoclast related effects on joint
turnover.
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Purpose: We have reported that the impairment of osteoclast
fusion had important roles for the delayed fracture healing in
streptozotocin (STZ)-induced diabetic mice. In this study, we fur-
ther investigated the mechanism of the malfunction of diabetic
osteoclasts using genetic analysis in vivo and cell culture in vitro.
Methods: The C57BL/6 mice were irradiated (9 Gy) and injected
with 4 × 106 bone marrow cells isolated from C57BL/6-EGFP
mice. The diabetes was induced by intravenous administration of
STZ (150 mg·kg-1 in mice). The control was injected with sodium
citrate buffer. At 6 weeks after transfer, bone marrow cells were
isolated from both the STZ and control groups, and then cultured
in the 96well dish with the cortical bone plate. The cortical bone
plates were extraction skull bones of wild type C57BL/6, and those
were ﬁxed and dehydrated with 100% ethanol. The cell culture was
performed in DMEM supplemented with 10% fetal bovine serum
under 5% CO2 and 95% air at 37 °C, and the ﬂoating cell was
removed after 2 h incubation. On day 3, 5, and 7, the cortical bone
plates were examined to analyze the formation of the resorption
pits by a scanning electron microscope.
The standardized closed fracture models were created in both the
control and STZ group. At 2 weeks after the fracture, the frozen
sections of the fracture site were created. The osteoclasts at
callus area were captured by laser capture microdissection (LCM).
We extracted RNA and synthesized cDNA by using commercial
kit. RT-PCR was performed to evaluate the mRNA expressions
of MMP9, Catepsin-K, Receptor activator of NF-kappaB (RANK),
dendritic cell-speciﬁc transmembrane protein (DC-STAMP), and
GAPDH.
